My bookmarksSign up free

Commission Implementing Regulation (EU) 2020/1511 of 16 October 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, picloram, prosulfocarb, sulphur, triflusulfuron and tritosulfuron (Text with EEA relevance)

Commission Implementing Regulation (EU) 2020/1511 of 16 October 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, picloram, prosulfocarb, sulphur, triflusulfuron and tritosulfuron (Text with EEA relevance)

Implementing Regulation (EU) 2020/1511 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2021’; (2) in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2021’; (3) in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2021’; (4) in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2021’; (5) in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2021’; (6) in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2021’; (7) in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2021’; (8) in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2021’; (9) in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2021’; (10) in the sixth column, expiration of approval, of row 160, Prosulfocarb, the date is replaced by ‘31 October 2021’; (11) in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘31 October 2021’; (12) in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘31 October 2021’; (13) in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘31 December 2021’; (14) in the sixth column, expiration of approval, of row 170, Nicosulfuron, the date is replaced by ‘31 December 2021’; (15) in the sixth column, expiration of approval, of row 171, Clofentezine, the date is replaced by ‘31 December 2021’; (16) in the sixth column, expiration of approval, of row 172, Dicamba, the date is replaced by ‘31 December 2021’; (17) in the sixth column, expiration of approval, of row 173, Difenoconazole, the date is replaced by ‘31 December 2021’; (18) in the sixth column, expiration of approval, of row 176, Lenacil, the date is replaced by ‘31 December 2021’; (19) in the sixth column, expiration of approval, of row 178, Picloram, the date is replaced by ‘31 December 2021’; (20) in the sixth column, expiration of approval, of row 180, Bifenox, the date is replaced by ‘31 December 2021’; (21) in the sixth column, expiration of approval, of row 181, Diflufenican, the date is replaced by ‘31 December 2021’; (22) in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘31 December 2021’; (23) in the sixth column, expiration of approval, of row 183, Fenpropidin, the date is replaced by ‘31 December 2021’; (24) in the sixth column, expiration of approval, of row 186, Tritosulfuron, the date is replaced by ‘30 November 2021’; (25) in the sixth column, expiration of approval, of row 289, Triflusulfuron, the date is replaced by ‘31 December 2021’; (26) in the sixth column, expiration of approval, of row 292, Sulphur, the date is replaced by ‘31 December 2021’; (27) in the sixth column, expiration of approval, of row 294, Paraffin oils, the date is replaced by ‘31 December 2021’.

Other acts of the same type
Commission Implementing Regulation (EU) 2025/142 of 29 January 2025 concerning the authorisation of a preparation of 6-phytase produced with Trichoderma reesei CBS 126897 as a feed additive for fin fish (holder of authorisation: AB Enzymes Finland Oy)Commission Implementing Regulation (EU) 2025/143 of 29 January 2025 concerning the authorisation of L-isoleucine produced with Corynebacterium glutamicum CGMCC 20437 as a feed additive for all animal speciesCommission Regulation (EU) 2025/146 of 29 January 2025 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for zoxamide in or on certain productsCommission Regulation (EU) 2025/147 of 29 January 2025 amending Annex I to Regulation (EC) No 1334/2008 of the European Parliament and of the Council as regards the removal of the flavouring substance 4-Methyl-2-phenylpent-2-enal (FL No 05.100) from the Union listCommission Implementing Regulation (EU) 2025/148 of 29 January 2025 concerning the renewal of the authorisation of a preparation of Enterococcus lactis NCIMB 11181 as a feed additive for calves for rearing and for fattening and weaned piglets (holder of authorisation: Chr. Hansen A/S) and repealing Implementing Regulation (EU) No 797/2013Commission Implementing Regulation (EU) 2025/150 of 29 January 2025 renewing the approval of the active substance mepiquat chloride in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011Commission Implementing Regulation (EU) 2025/151 of 29 January 2025 concerning the renewal of the authorisation of a preparation of Levilactobacillus brevis DSM 21982 as a feed additive for all animal species and repealing Implementing Regulation (EU) No 838/2012Commission Implementing Regulation (EU) 2025/152 of 29 January 2025 concerning the authorisation of omicha tincture from Schisandra chinensis (Turcz.) Baill. and ginseng tincture from Panax ginseng C.A.Mey. as feed additives for certain animal speciesCommission Implementing Regulation (EU) 2025/153 of 29 January 2025 authorising the placing on the market of Lemna minor and Lemna gibba plants as novel food and amending Implementing Regulation (EU) 2017/2470Commission Implementing Regulation (EU) 2025/154 of 29 January 2025 concerning the authorisation of a preparation of Saccharomyces cerevisiae DSM 34246 as a feed additive for dogs and cats (holder of authorisation: ACEL pharma s.r.l.)Commission Implementing Regulation (EU) 2025/157 of 29 January 2025 concerning the authorisation of microcrystalline cellulose, methyl cellulose, ethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose and sodium carboxymethyl cellulose as feed additives for all animal speciesCommission Regulation (EU) 2025/158 of 29 January 2025 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid in or on certain products

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next